المنشورات طباعة Bush A, Liu CM, Rula EY, Luh J, Yu NY, Laack N, Attia A, Waddle M. Caught Between a Radiation Oncology Case Rate (ROCR) and a Hard Place: Improving Proposed Radiation Oncology Alternative Payment Models. Int J Radiat Oncol Biol Phys. 2024 Dec 1; 120 (5):1214-1225 Epub 2024 July 09 View PubMed Chen J, Yang Y, Feng H, Zhang L, Liu Z, Liu T, Vargas CE, Yu NY, Rwigema JM, Keole SR, Patel SH, Vora SA, Shen J, Liu W. Robust Optimization for Spot Scanning Proton Therapy based on Dose-Linear Energy Transfer (LET) Volume Constraints. Int J Radiat Oncol Biol Phys. 2024 Nov 15 [Epub ahead of print] View PubMed Duan J, Tegtmeier RC, Vargas CE, Yu NY, Laughlin BS, Rwigema JM, Anderson JD, Zhu L, Chen Q, Rong Y. Achieving accurate prostate auto-segmentation on CT in the absence of MR imaging. Radiother Oncol. 2024 Oct 16; 202:110588 [Epub ahead of print] View PubMed Rades D, Lomidze D, Jankarashvili N, Lopez Campos F, Navarro-Martin A, Segedin B, Groselj B, Staackmann C, Yu NY, Cacicedo J. Radiotherapy with 15 x 2.633 Gy vs. 20 x 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 Trial. Cancers (Basel). 2024 Oct 10; 16 (20) View PubMed Feng H, Shan J, Vargas CE, Keole SR, Rwigema JM, Yu NY, Ding Y, Zhang L, Hu Y, Schild SE, Wong WW, Vora SA, Shen J, Liu W. Online Adaptive Proton Therapy Facilitated by Artificial Intelligence-Based Autosegmentation in Pencil Beam Scanning Proton Therapy. Int J Radiat Oncol Biol Phys. 2024 Sep 20 Epub 2024 Sept 20 View PubMed Tegtmeier RC, Clouser EL, Laughlin BS, Santos Toesca DA, Flakus MJ, Bashir S, Kutyreff CJ, Hobbis D, Harrington DP, Smetanick JL, Yu NY, Vargas CE, James SE, Rwigema JM, Rong Y. Evaluation of knowledge-based planning models for male pelvic CBCT-based online adaptive radiotherapy on conventional linear accelerators. J Appl Clin Med Phys. 2024 Sep; 25 (9):e14464 Epub 2024 July 19 View PubMed Zemskova O, Yu NY, Leppert J, Loser A, Rades D. Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma? In Vivo. 2024 Sep-Oct; 38 (5):2341-2348 View PubMed Rades D, Zemskova O, Leppert J, Yu NY. The Predictive Value of Different Glasgow Prognostic Scores and the LabBM Score for Patients With Recurrent Glioblastoma. Anticancer Res. 2024 Sep; 44 (9):3973-3981 View PubMed Liu W, Feng H, Taylor PA, Kang M, Shen J, Saini J, Zhou J, Giap HB, Yu NY, Sio TS, Mohindra P, Chang JY, Bradley JD, Xiao Y, Simone CB 2nd, Lin L. NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies. Int J Radiat Oncol Biol Phys. 2024 Jul 15; 119 (4):1208-1221 Epub 2024 Feb 22 View PubMed Peng Y, Kumar AV, Gu Z, Kosuru N, Wampfler JA, Reck Dos Santos PA, Yu NY, D'Cunha J, Ernani V, Costello CM, Yang P. Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort. J Am Acad Dermatol 2024 Jul; 91 (1):172-175 Epub 2024 Mar 29 View PubMed Zemskova O, Yu NY, Leppert J, Rades D. Prognostic Factors for Progression-free Survival and Overall Survival After Recurrence of Glioblastoma. Anticancer Res. 2024 Jul; 44 (7):3059-3066 View PubMed Zemskova O, Yu NY, Loser A, Leppert J, Rades D. Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma Multiforme. In Vivo. 2024 Jul-Aug; 38 (4):1806-1813 View PubMed Zemskova O, Yu NY, Loser A, Leppert J, Rades D. Prognostic Role of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Irradiated for Glioblastoma Multiforme. Cancer Diagn Progn. 2024 Jul-Aug; 4 (4):408-415 Epub 2024 July 03 View PubMed Rades D, Janssen S, Narvaez-Wolf CA, Kristiansen C, Timke C, Duma MN, Bartscht T, Yu NY. Seasonal Impact on Grade >/=2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis. Anticancer Res. 2024 Jun; 44 (6):2617-2620 View PubMed Valdes G, Scholey J, Nano TF, Gennatas ED, Mohindra P, Mohammed N, Zeng J, Kotecha R, Rosen LR, Chang J, Tsai HK, Urbanic JJ, Vargas CE, Yu NY, Ungar LH, Eaton E, Simone CB 2nd. Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2024 May 1; 119 (1):66-77 Epub 2023 Nov 23 View PubMed Rades D, Cremers F, Janssen S, Bartscht T, Kristiansen C, Timke C, Duma MN, Yu NY, Bohnet S. Associations Between Mean Lung Dose and Prevalence of Radiation Pneumonitis in Elderly Lung Cancer Patients. Anticancer Res. 2024 May; 44 (5):2073-2079 View PubMed Rades D, Zemskova O, Gliemroth J, Yu NY. The Role of Radiotherapy for Meningeal Melanocytomas - A 20 Year Update. In Vivo. 2024 May-Jun; 38 (3):1220-1228 View PubMed Rades D, Kristiansen C, Timke C, Duma MN, Yu NY, Bartscht T, Janssen S. Clinically Significant Dermatitis During Adjuvant Radiotherapy for Invasive Breast Cancer. Anticancer Res. 2024 Apr; 44 (4):1525-1531 View PubMed Zhang L, Holmes JM, Liu Z, Vora SA, Sio TT, Vargas CE, Yu NY, Keole SR, Schild SE, Bues M, Li S, Liu T, Shen J, Wong WW, Liu W. Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy. Med Phys. 2024 Feb; 51 (2):1484-1498 Epub 2023 Sept 25 View PubMed Rades D, Delikanli C, Yu NY, Janssen S. Distress Scores in Elderly Cancer Patients During Radiotherapy. In Vivo. 2024 Jan-Feb; 38 (1):313-320 View PubMed Laughlin BS, Anderson JD, Hobbis D, Armstrong M, Vargas CE, Rong Y, Yu NY. Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer. BJU Int. 2023 Dec; 132 (6):648-650 Epub 2023 Aug 21 View PubMed Agarwal M, Liu A, Almquist D, Langlais BT, Leventakos K, Yu NY, Manochakian R, Ernani V. Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status. Cancer. 2023 Nov 15; 129 (22):3546-3553 Epub 2023 Aug 07 View PubMed Delikanli C, Janssen S, Yu NY, Rades D. Development of Distress During a Radiotherapy Course in Patients Irradiated for Breast Cancer. In Vivo. 2023 Nov-Dec; 37 (6):2755-2759 View PubMed Rades D, Eggert MC, Janssen S, Yu NY. Whole-breast Radiotherapy With Boost for Node-negative Breast Cancer: Conventional vs. Hypo-fractionation. In Vivo. 2023 Nov-Dec; 37 (6):2628-2633 View PubMed Agarwal M, Liu A, Langlais BT, Leventakos K, Yu NY, Almquist D, Manochakian R, Ernani V. Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3. Clin Lung Cancer. 2023 Nov; 24 (7):591-597 Epub 2023 May 26 View PubMed Munoz EP, Patel SP, Leachman SA, Yu NY, Yu WY. Minority enrollment in melanoma clinical trials. J Am Acad Dermatol. 2023 Nov; 89 (5):1052-1054 Epub 2023 July 05 View PubMed Ding Y, Feng H, Yang Y, Holmes J, Liu Z, Liu D, Wong WW, Yu NY, Sio TT, Schild SE, Li B, Liu W. Deep-learning based fast and accurate 3D CT deformable image registration in lung cancer. Med Phys. 2023 Nov; 50 (11):6864-6880 Epub 2023 June 08 View PubMed Eggert MC, Yu NY, Rades D. Radiation Dermatitis and Pneumonitis in Patients Irradiated for Breast Cancer. In Vivo. 2023 Nov-Dec; 37 (6):2654-2661 View PubMed Eggert MC, Janssen S, Yu NY, Rades D. Simultaneous vs. Sequential Boost for Adjuvant Breast Radiotherapy. Anticancer Res. 2023 Oct; 43 (10):4651-4655 View PubMed Rades D, Delikanli C, Janssen S, Bohnet S, Yu NY. Distress Scores During Radiotherapy for Lung Cancer: Course and Prognostic Factors. Cancer Diagn Progn. 2023 Sep-Oct; 3 (5):577-581 Epub 2023 Sept 03 View PubMed Delikanli C, Janssen S, Tvilsted S, Yu NY, Rades D. Final Results of a Study Evaluating the Course of Distress Scores During Radiotherapy for Malignant Diseases. Anticancer Res. 2023 Sep; 43 (9):4143-4148 View PubMed Rades D, Delikanli C, Yu NY, Janssen S. Development of Distress During a Radiotherapy Course for Head-and-neck Cancer. Anticancer Res. 2023 Sep; 43 (9):4149-4153 View PubMed Janssen S, Delikanli C, Yu NY, Rades D. Comparison of Distress Scores Before and After Radiotherapy for Prostate Cancer. In Vivo. 2023 Sep-Oct; 37 (5):2173-2177 View PubMed Rades D, Zwaan I, Idel C, Pries R, Bruchhage KL, Hakim SG, Yu NY, Soror T. A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer. J Pers Med. 2023 Jul 10; 13 (7) Epub 2023 July 10 View PubMed Zemskova O, Pedachenko E, Yu NY, Rades D. Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma. Anticancer Res. 2023 Jul; 43 (7):3121-3128 View PubMed Rades D, Johannwerner L, Werner EM, Cremers F, Gliemroth J, Yu NY. Whole-brain Radiotherapy With or Without a Simultaneous Integrated Boost for Treatment of Brain Metastases. Anticancer Res. 2023 Jul; 43 (7):3107-3112 View PubMed Duan J, Vargas CE, Yu NY, Laughlin BS, Toesca DS, Keole S, Rwigema JCM, Wong WW, Schild SE, Feng X, Chen Q, Rong Y. Incremental retraining, clinical implementation, and acceptance rate of deep learning auto-segmentation for male pelvis in a multiuser environment. Med Phys. 2023 Jul; 50(7):4079-4091. Epub 2023 Jun 07. View PubMed Rades D, Zwaan I, Soror T, Idel C, Pries R, Bruchhage KL, Hakim SG, Yu NY. Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN). Cancers (Basel). 2023 Jun 21; 15 (13) Epub 2023 June 21 View PubMed Zwaan I, Soror T, Idel C, Pries R, Bruchhage KL, Hakim SG, Yu NY, Rades D. First Results of Concurrent Chemoradiation with Two Courses of 5 x 25 mg/m(2) Cisplatin for Locally Advanced Head and Neck Cancer. J Pers Med. 2023 Jun 16; 13 (6) Epub 2023 June 16 View PubMed Johannwerner L, Werner EM, Janssen S, Yu NY, Rades D. Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases. Anticancer Res. 2023 Jun; 43 (6):2757-2762 View PubMed Zemskova O, Yu NY, Trillenberg P, Bonsanto MM, Leppert J, Rades D. Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy. Anticancer Res. 2023 Jun; 43 (6):2725-2732 View PubMed Rades D, Johannwerner L, Yu NY, Gliemroth J. Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain Metastases. Anticancer Res. 2023 Jun; 43 (6):2763-2770 View PubMed Rades D, Al-Salool A, Yu NY, Soror T. Pre-treatment Emotional Distress in Patients Receiving Radiotherapy for Gynecologic Cancers. Cancer Diagn Progn. 2023 May-Jun; 3 (3):320-326 Epub 2023 May 03 View PubMed Rades D, Al-Salool A, Bohnet S, Yu NY. Prevalence of and Risk Factors for Emotional Distress in Patients Undergoing Radiotherapy for Lung Cancer. Anticancer Res. 2023 May; 43 (5):2111-2118 View PubMed Al-Salool A, Soror T, Yu NY, Idel C, Bruchhage KL, Hakim SG, Rades D. Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy Alone. Anticancer Res. 2023 May; 43 (5):2227-2233 View PubMed Al-Salool A, Soror T, Yu NY, Rades D. Prevalence and Risk Factors of Emotional Distress in Patients With Prostate Cancer Assigned to External-beam Radiotherapy With or Without High-dose Rate Brachytherapy. Anticancer Res. 2023 May; 43 (5):2103-2109 View PubMed Rades D, Al-Salool A, Yu NY, Bartscht T. Emotional Distress Prior to Chemoradiation for Rectal or Anal Cancer. In Vivo. 2023 May-Jun; 37 (3):1205-1210 View PubMed Rades D, Al-Salool A, Yu NY, Trillenberg P, Bonsanto MM, Leppert J. Pre-treatment Emotional Distress in Patients Irradiated for Malignant Glioma. In Vivo. 2023 May-Jun; 37 (3):1198-1204 View PubMed Johannwerner L, Werner EM, Blanck O, Janssen S, Cremers F, Yu NY, Rades D. Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases. Biology (Basel). 2023 Apr 26; 12 (5) View PubMed Rades D, Johannwerner L, Werner EM, Cremers F, Yu NY. The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases. Biology (Basel). 2023 Apr 12; 12 (4) View PubMed Ernani V, Appiah AK, Rodriguez D, Kusne Y, Beamer SE, Ravanbakhsh S, Jaroszewski D, Reck Dos Santos P, Sio TT, Yu N, Yang P, Schild S, D'Cunha J. Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database. Cancer. 2023 Mar 15; 129 (6):860-866 Epub 2022 Dec 22 View PubMed Rades D, Zwaan I, Janssen S, Yu NY, Schild SE, Idel C, Pries R, Hakim SG, Soror T. Evaluation of the Impact of Smoking and Alcohol Consumption on Toxicity and Outcomes of Chemoradiation for Head and Neck Cancer. Anticancer Res. 2023 Feb; 43 (2):823-830 View PubMed Hobbis D, Yu NY, Mund KW, Duan J, Rwigema JM, Wong WW, Schild SE, Keole SR, Feng X, Chen Q, Vargas CE, Rong Y. First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy Patients. Pract Radiat Oncol. 2023 Jul-Aug; 13(4):351-362. Epub 2023 Apr 06. View PubMed Laughlin BS, Yu NY, Lo S, Duan J, Welchel Z, Tinnon K, Beckett M, Schild SE, Wong WW, Keole SR, Rwigema JM, Vargas CE, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance. Cancers (Basel). 2022 Dec 21; 15 (1) View PubMed Laughlin BS, Lo S, Vargas CE, DeWees TA, Van der Walt C, Tinnon K, Beckett M, Hobbis D, Schild SE, Wong WW, Keole SR, Rwigema JM, Yu NY, Clouser E, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 1: Consistent Organs at Risk Management with Advanced Image Guidance. Cancers (Basel). 2022 Dec 20; 15 (1) View PubMed Yang Y, Rwigema JM, Vargas C, Yu NY, Keole SR, Wong WW, Schild SE, Bues M, Liu W, Shen J. Technical note: Investigation of dose and LET(d) effect to rectum and bladder by using non-straight laterals in prostate cancer receiving proton therapy. Med Phys. 2022 Dec; 49 (12):7428-7437 Epub 2022 Oct 18 View PubMed Yu NY, DeWees TA, Voss MM, Breen WG, Chiang JS, Ding JX, Daniels TB, Owen D, Olivier KR, Garces YI, Park SS, Sarkaria JN, Yang P, Savvides PS, Ernani V, Liu W, Schild SE, Merrell KW, Sio TT. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022 Dec; 23 (8):e526-e535 Epub 2022 Aug 10 View PubMed Laughlin BS, Ashman JB, Rule WG, Yu NY, Sio TT. Excellent clinical outcomes can be achieved with neoadjuvant chemoradiation and orthotopic liver transplantation for unresectable cholangiocarcinoma: support for the need of an international transplant protocol. J Gastrointest Oncol. 2022 Oct; 13 (5):2699-2700 View PubMed Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung Cancer. 2022 Aug; 170:58-64 Epub 2022 June 13 View PubMed Penoncello GP, Gagneur JD, Vora SA, Yu NY, Fatyga M, Mrugala MM, Bendok BR, Rong Y. Comprehensive Commissioning and Clinical Implementation of GammaTiles STaRT for Intracranial Brain Cancer. Adv Radiat Oncol. 2022 Jul-Aug; 7 (4):100910 Epub 2022 Feb 05 View PubMed Laughlin BS, Petersen MM, Yu NY, Anderson JD, Rule WG, Borad MJ, Aqel BA, Sonbol MB, Mathur AK, Moss AA, Bekaii-Saab TS, Ahn DH, DeWees TA, Sio TT, Ashman JB. Clinical outcomes for hilar and extrahepatic cholangiocarcinoma with adjuvant, definitive, or liver transplant-based neoadjuvant chemoradiotherapy strategies: a single-center experience. J Gastrointest Oncol. 2022 Feb; 13 (1):288-297 View PubMed Yu NY, Sio TT, Ernani V, Savvides P, Schild SE. Role of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer. J Natl Compr Canc Netw. 2021 Dec; 19 (12):1465-1469 View PubMed Chiang JS, Yu NY, Sheedy JT, Hayden RE, Lemish PR, Karlin NJ, Mishra N, Sio TT. Radiotherapeutic Management of Synchronous Prostate and Rectal Cancers Using Proton Beam Therapy. Int J Part Ther. 2021 Fall; 8 (2):82-88 Epub 2021 Apr 20 View PubMed Younkin JE, Morales DH, Shen J, Ding X, Stoker JB, Yu NY, Sio TT, Daniels TB, Bues M, Fatyga M, Schild SE, Liu W. Technical Note: Multiple energy extraction techniques for synchrotron-based proton delivery systems may exacerbate motion interplay effects in lung cancer treatments. Med Phys. 2021 Sep; 48 (9):4812-4823 Epub 2021 July 29 View PubMed Feng H, Shan J, Ashman JB, Rule WG, Bhangoo RS, Yu NY, Chiang J, Fatyga M, Wong WW, Schild SE, Sio TT, Liu W. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma. Med Phys. 2021 Aug; 48 (8):4636-4647 Epub 2021 June 24 View PubMed Yu NY, Khurana A, Ma DJ, Neben-Wittich MA, Golafshar MA, McGee LA, Rwigema JM, Foote RL, Patel SH. Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer. Int J Part Ther. 2021 Summer; 8 (1):311-318 Epub 2021 June 25 View PubMed Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze KL, Golafshar M, Uson PLS Jr, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez EA, Lizaola-Mayo B, Lehrer M, Thorpe CS, Yu NY, Esplin ED, Nussbaum RL, Sharp RR, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce AH, Bekaii-Saab TS, Sekulic A, Stewart AK. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA Oncol. 2021 Feb 1; 7 (2):230-237 View PubMed Chiang JS, Yu NY, Daniels TB, Liu W, Schild SE, Sio TT. Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations. J Thorac Dis. 2021 Feb; 13 (2):1270-1285 View PubMed Patel NV, Yu NY, Koroulakis A, Diwanji T, Sawant A, Sio TT, Mohindra P. Proton therapy for thoracic malignancies: a review of oncologic outcomes. Expert Rev Anticancer Ther. 2021 Feb; 21 (2):177-191 Epub 2021 Jan 08 View PubMed Breen WG, Jethwa KR, Yu NY, Spears GM, Harmsen WS, Miller RC, Ashman JB, Rule WG, Sio TT, Neben-Wittich MA, Haddock MG, Mahipal A, Truty MJ, Hallemeier CL, Merrell KW. Patient-Reported Quality of Life Before and After Chemoradiation for Intact Pancreas Cancer: A Prospective Registry Study. Pract Radiat Oncol. 2021 Jan-Feb; 11 (1):e63-e69 Epub 2020 July 23 View PubMed Yu NY, Sio TT, Lyons MK, Vora SA, Turkmani A, Brown PD, Park SS, Leenstra JL, Bendok BR, Schild SE, Ashman JB. Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience. J Clin Neurosci. 2020 Oct; 80:74-78 Epub 2020 Aug 17 View PubMed Yu NY, Niska JR. Azygous tumor thrombus extending into the heart. J Cardiovasc Comput Tomogr 2020 Sep - Oct; 14 (5):e9-e10 Epub 2018 Oct 06 View PubMed Bhangoo RS, DeWees TA, Yu NY, Ding JX, Liu C, Golafshar MA, Rule WG, Vora SA, Ross HJ, Ahn DH, Beamer SE, Jaroszewski DE, Hallemeier CL, Liu W, Ashman JB, Sio TT. Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience. Adv Radiat Oncol. 2020 Sep-Oct; 5 (5):871-879 Epub 2020 May 19 View PubMed Yu NY, Lee M, Petersen MM, Ashman JB, Vora SA, DeWees TA, Laack NN, Mahajan A, Merrell KM, Lyons MK, Mrugala MM, Bendok BR, Porter AB, Peterson JL, Brown PD, Sio TT. Trimodality therapy is associated with improved overall survival in gliosarcoma: A multi-site experience. Int J Radiat Oncol Biol Physics. 2020; 108(3):e681. Yu NY, DeWees TA, Alam M, Ochoa SA, Mangold AR, Steidley DE, Vargas HE, Golafshar MA, Schild SE, Halyard MY, Patel SH. Risk of Recurrence and 10-Year Outcomes in Surgically Treated Nonmelanoma Skin Cancer in Cardiac and Liver Transplant Recipients. Am J Clin Oncol. 2020 May; 43 (5):366-370 View PubMed Yu NY, DeWees TA, Liu C, Daniels TB, Ashman JB, Beamer SE, Jaroszewski DE, Ross HJ, Paripati HR, Rwigema JM, Ding JX, Shan J, Liu W, Schild SE, Sio TT. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience. Adv Radiat Oncol. 2020 May-Jun; 5 (3):450-458 Epub 2019 Aug 21 View PubMed Cheng TW, Yu NY, Seetharam M, Patel SH. Radiotherapy for malignant melanoma of the lacrimal sac. Rare Tumors. 2020; 12:2036361320971943 Epub 2020 Nov 11 View PubMed Chiang JS, Yu NY, Ertz-Archambault NM, Karlin NJ, Shoudis SN, Sio TT. Palliative radiotherapy for hepatobiliary obstruction caused by colorectal metastases. J Gastrointest Oncol. 2019 Dec; 10 (6):1157-1161 View PubMed Liu C, Yu NY, Shan J, Bhangoo RS, Daniels TB, Chiang JS, Ding X, Lara P, Patrick CL, Archuleta JP, DeWees T, Hu Y, Schild SE, Bues M, Sio TT, Liu W. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC). Med Phys. 2019 Nov; 46 (11):4755-4762 Epub 2019 Sept 21 View PubMed Sio TT, Mohindra P, Yu NY, Ashman JB, Daniels TB, Merrell KW, Schild SE. The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues. J Clin Oncol 2019 Oct 10; 37 (29):2697-2699 Epub 2019 Aug 29 View PubMed Yu NY, Gamez ME, Hartsell WF, Tsai HK, Laramore GE, Larson GL, Simone CB 2nd, Rossi C, Katz SR, Buras MR, Golafshar MA, Vargas CE, Patel SH. A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors. Adv Radiat Oncol. 2019 Oct-Dec; 4 (4):689-698 Epub 2019 July 16 View PubMed Liu C, Bhangoo RS, Sio TT, Yu NY, Shan J, Chiang JS, Ding JX, Rule WG, Korte S, Lara P, Ding X, Bues M, Hu Y, DeWees T, Ashman JB, Liu W. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies. J Appl Clin Med Phys. 2019 Jul; 20 (7):15-27 Epub 2019 May 21 View PubMed Yu NY, Gamez ME. Black Thyroid. Int J Surg Pathol. 2019 Jun; 27 (4):401-402 Epub 2018 Sept 17 View PubMed Erikson AK, Yu NY, Sheedy JT, Shoudis SN, Paripati HR, Sio TT. Erlotinib-Associated Rash Exacerbated by Whole-Brain Radiation Therapy: A Patient's Case Report. Pract Radiat Oncol. 2019 May; 9 (3):128-131 Epub 2019 Feb 13 View PubMed Yu NY, Rule WG, Sio TT, Ashman JB, Nelson KL. Radiation Contamination Following Cremation of a Deceased Patient Treated With a Radiopharmaceutical. JAMA. 2019 Feb 26; 321 (8):803-804 View PubMed Yu NY, Vora SA. Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma. Rare Tumors. 2019; 11:2036361319878518 Epub 2019 Sept 23 View PubMed Yu NY, Deftos M, Wang CC. Pneumonitis in Combined Anti-programmed Death-1 Immunotherapy and Radiation Therapy for Renal Cell Carcinoma. Cureus. 2018 Dec 18; 10 (12):e3748 View PubMed Yu NY, Wolfson T, Middleton MS, Hamilton G, Gamst A, Angeles JE, Schwimmer JB, Sirlin CB. Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease. Clin Radiol. 2017 May; 72 (5):425.e9-425.e14 Epub 2017 Jan 05 View PubMed Yu NY, Sanghvi P. Nonmelanoma subungual malignancies: A case-based review of radiation therapy. Pract Radiat Oncol. 2016 Mar-Apr; 6 (2):126-8 Epub 2015 Sept 25 View PubMed PST-20519749 الصفحة الرئيسية المنشورات